|
Symbiotec Pharmalab Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
6928.42 Cr.
|
P/BV
|
6.02
|
Book Value (Rs.)
|
178.98
|
|
52 Week High/Low (Rs.)
|
1180/934
|
FV/ML
|
2/1
|
P/E(X)
|
63.05
|
|
Bookclosure
|
|
EPS (Rs.)
|
17.10
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 |
| | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 153.36 | 146.98 | 130.98 |
| | | | |
| Net CashFlow From Operating Activities | 174.59 | 47.26 | 187.50 |
| Net Cash Used In Investing Activities | -226.93 | -306.52 | -206.41 |
| Net Cash Used From Financing Activities | 35.99 | 278.16 | 21.85 |
| | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -16.35 | 18.90 | 2.94 |
| Cash And Cash Equivalents Begin of Year | 26.39 | 7.50 | 4.55 |
| Cash And Cash Equivalents End Of Year | 10.04 | 26.39 | 7.50 |